机译:EGFR表达增加,三体性7和相关的局灶性侵袭的囊性顶分泌导管癌
Department of Pathology, Shizuoka Saiseikai General Hospital, 1-1-1 Oshika, Suruga-ku, Shizuoka 422-8021, Japan;
Department of Cell Biology and Anatomy, Hamamatsu University School of Medicine, Shizuoka, Japan;
Department of Radiology, Hamamatsu University School of Medicine, Shizuoka, Japan;
Department of Surgery I, Hamamatsu University School of Medicine, Shizuoka, Japan;
Apocrine ductal carcinoma in situ; Invasive apocrine carcinoma; Epidermal growth factor receptor; Chromosome 7; Trisomy;
机译:细胞角蛋白标志物,ER-alpha,PR,HER-2 / neu和EGFR在乳腺原位导管癌(DCIS)和DCIS与并存的浸润性导管癌(IDC)中的表达。
机译:浸润性多形性小叶癌伴原位导管和小叶载脂腺癌的主分泌分化:病例报告
机译:HER-2 / neu和Paxillin在原位导管癌,浸润性导管癌合并导管癌和黏液癌中的表达
机译:乳腺浸润性微乳头状癌中CD146的表达增加和微血管密度(MVD):与浸润性导管癌的比较研究(未另作说明)
机译:14-3-3 Zeta介导的上皮-间质转化(EMT)有助于ErbB2过表达导管原位癌(DCIS)演变为浸润性乳腺癌
机译:增加的SIAH表达预测导管癌原位(DCIS)进程对侵入性癌
机译:乳腺原位癌与浸润癌相关:同一个乳腺的核分级和p53,C-erbB-2蛋白和雌激素受体的表达分析乳腺原位癌和浸润癌在同一乳腺的评估蛋白p53,C-erbB-2和雌激素受体的表达